Literature DB >> 30277153

Conventional Versus Natural Alternative Treatments for Leishmaniasis: A Review.

Luiz Felipe Domingues Passero1,2, Lucas Antal Cruz1, Gabriela Santos-Gomes3, Eliana Rodrigues4, Márcia Dalastra Laurenti5, João Henrique Ghilardi Lago6.   

Abstract

Leishmaniasis is a neglected disease caused by protozoan belonging to the Leishmania genus. There are at least 16 pathogenic species for humans that are able to cause different clinical forms, such as cutaneous or visceral leishmaniasis. In spite of the different species and clinical forms, the treatment is performed with few drug options that, in most cases, are considered outdated. In addition, patients under classical treatment show serious side effects during drug administration, moreover parasites are able to become resistant to medicines. Thus, it is believed and well accepted that is urgent and necessary to develop new therapeutic options to overpass these concerns about conventional therapy of leishmaniasis. The present review will focus on the efficacy, side effects and action mechanism of classic drugs used in the treatment of leishmaniasis, as well as the importance of traditional knowledge for directing a rational search toward the discovery and characterization of new and effective molecules (in vivo assays) from plants to be used against leishmaniasis. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Amphotericin; Conventional drugs; Ethnopharmacology; Leishmaniasis; Molecules; New drugs.

Mesh:

Substances:

Year:  2018        PMID: 30277153     DOI: 10.2174/1568026618666181002114448

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  4 in total

1.  Potential of the natural products against leishmaniasis in Old World - a review of in-vitro studies.

Authors:  Sofia Cortes; Carolina Bruno de Sousa; Thiago Morais; João Lago; Lenea Campino
Journal:  Pathog Glob Health       Date:  2020-04-27       Impact factor: 2.894

2.  A clioquinol-containing Pluronic® F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model.

Authors:  Grasiele S V Tavares; Débora V C Mendonça; Isabela A G Pereira; João A Oliveira-da-Silva; Fernanda F Ramos; Daniela P Lage; Amanda S Machado; Lívia M Carvalho; Thiago A R Reis; Luísa Perin; Ana Maria R S Carvalho; Flaviano M Ottoni; Fernanda Ludolf; Camila S Freitas; Raquel S Bandeira; Alessandra M Silva; Miguel A Chávez-Fumagalli; Mariana C Duarte; Daniel Menezes-Souza; Ricardo J Alves; Bruno M Roatt; Eduardo A F Coelho
Journal:  Parasite       Date:  2020-04-30       Impact factor: 3.000

Review 3.  The Potential of Traditional Knowledge to Develop Effective Medicines for the Treatment of Leishmaniasis.

Authors:  Luiz Felipe D Passero; Erika Dos Santos Brunelli; Thamara Sauini; Thais Fernanda Amorim Pavani; Jéssica Adriana Jesus; Eliana Rodrigues
Journal:  Front Pharmacol       Date:  2021-06-08       Impact factor: 5.810

4.  Preclinical Assessment of Ursolic Acid Loaded into Nanostructured Lipid Carriers in Experimental Visceral Leishmaniasis.

Authors:  Jéssica Adriana Jesus; Ilza Maria Oliveira Sousa; Thays Nicolli Fragoso da Silva; Aurea Favero Ferreira; Márcia Dalastra Laurenti; Leila Antonangelo; Caroline Silvério Faria; Paulo Cardoso da Costa; Domingos de Carvalho Ferreira; Luiz Felipe Domingues Passero
Journal:  Pharmaceutics       Date:  2021-06-19       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.